ICD-10 Coding for Follicular Lymphoma(C82.0, C82.1, C82.2, C82.9)
Complete ICD-10-CM coding and documentation guide for Follicular Lymphoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Follicular Lymphoma
C82.0-C82.9Primary Range
Follicular lymphoma codes
This range covers all grades of follicular lymphoma, specifying the number of centroblasts per high power field.
Personal history of follicular lymphoma
Used to indicate a history of follicular lymphoma in patient records.
Complications of immune effector cellular therapy
Relevant for cases involving CAR-T therapy for follicular lymphoma.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C82.0 | Follicular lymphoma grade I | Use when biopsy confirms grade I follicular lymphoma. |
|
| C82.1 | Follicular lymphoma grade II | Use when biopsy confirms grade II follicular lymphoma. |
|
| C82.2 | Follicular lymphoma grade III | Use when biopsy confirms grade III follicular lymphoma. |
|
| C82.9 | Follicular lymphoma, unspecified | Use when specific grade is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for follicular lymphoma
Essential facts and insights about Follicular Lymphoma
Primary ICD-10-CM Codes for follicular lymphoma
Decision Criteria
clinical Criteria
- Biopsy confirms 0-5 centroblasts/HPF.
Applicable To
- Follicular lymphoma with 0-5 centroblasts per high power field
Excludes
- Diffuse large B-cell lymphoma (C83.3)
Clinical Validation Requirements
- Biopsy report confirming 0-5 centroblasts/HPF
- Flow cytometry showing CD20+, CD10+ B-cells
Code-Specific Risks
- Misclassification if centroblast count is not documented.
Coding Notes
- Ensure biopsy reports are reviewed for accurate grading.
C82.1 - Follicular lymphoma grade II
Use when biopsy confirms grade II follicular lymphoma.
Applicable To
- Follicular lymphoma with 6-15 centroblasts per high power field
Excludes
- Diffuse large B-cell lymphoma (C83.3)
Clinical Validation Requirements
- Biopsy report confirming 6-15 centroblasts/HPF
- Flow cytometry showing CD20+, CD10+ B-cells
Coding Notes
Ensure biopsy reports are reviewed for accurate grading.
C82.2 - Follicular lymphoma grade III
Use when biopsy confirms grade III follicular lymphoma.
Applicable To
- Follicular lymphoma with ≥15 centroblasts per high power field
Excludes
- Diffuse large B-cell lymphoma (C83.3)
Clinical Validation Requirements
- Biopsy report confirming ≥15 centroblasts/HPF
- Flow cytometry showing CD20+, CD10+ B-cells
Coding Notes
Ensure biopsy reports are reviewed for accurate grading.
C82.9 - Follicular lymphoma, unspecified
Use when specific grade is not documented.
Applicable To
- Follicular lymphoma without specified grade
Excludes
- Diffuse large B-cell lymphoma (C83.3)
Clinical Validation Requirements
- General diagnosis of follicular lymphoma without specific grading.
Coding Notes
Encourage documentation of specific grade to avoid unspecified coding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Personal history of follicular lymphoma
Z85.72Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Diffuse large B-cell lymphoma
C83.3Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Follicular Lymphoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C82.0.
Impact
Clinical: Inaccurate staging and treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for reduced reimbursement.
Mitigation Strategy
Train staff on importance of site documentation., Use templates that prompt for site details.
Impact
Reimbursement: Incorrect DRG assignment can lead to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation Strategy
Ensure documentation specifies histologic grade, not clinical stage.
Impact
Reimbursement: Potential for lower reimbursement rates., Compliance: Non-compliance with specificity requirements., Data Quality: Loss of detailed clinical information.
Mitigation Strategy
Review pathology reports for specific grade and document accordingly.
Impact
High risk of audit for using unspecified codes when specific grades are documented.
Mitigation Strategy
Implement mandatory review of pathology reports for grade documentation.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Follicular Lymphoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Follicular Lymphoma
Use these documentation templates to ensure complete and accurate documentation for Follicular Lymphoma. These templates include all required elements for proper coding and billing.
Pathology Report for Follicular Lymphoma
Specialty: Hematology/OncologyRequired Elements
- Diagnosis
- Site
- Centroblast Count
- Immunophenotype
- DLBCL Transformation
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Follicular Lymphoma? Ask your questions below.